Page 156 - நாஸ்டாக் உலகளாவிய தேர்ந்தெடுக்கவும் சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stealthgas Inc Says Market Turbulence Could Last Throughout 2021, as Company Reports Steady 2020 Revenues of $145 Million
hellenicshippingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hellenicshippingnews.com Daily Mail and Mail on Sunday newspapers.
theScore Announces Pricing of Upsized Initial Public Offering in the United States
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
DBV Technologies S.A.: DBV Technologies to Participate in Upcoming AAAAI 2021 Congress
DBV Technologies to Participate in Upcoming AAAAI 2021 Congress
DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced upcoming participation at the virtual American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Scientific meeting, February 26 - March 1, 2021. Two scientific presentations have been accepted, including one clinical and one non-clinical poster. DBV will also host a virtual booth in the AAAAI virtual exhibit hall.
The data to be presented will discuss a post-hoc analysis of the 12-month Phase 3 PEPITES clinical trial, showing that daily epicutaneous immunotherapy (EPIT) with DBV712 250 µg may reduce the severity of allergic reactions in peanut-allergic children aged 4 to 11 years. Additionally, DBV will present pre-clinical data suggesting that EPIT reduced mast-cell degranulation v
InnovAge Announces Launch of Initial Public Offering
DENVER, Feb. 24, 2021 (GLOBE NEWSWIRE) InnovAge Holding Corp. (InnovAge) today announced the launch of its initial public offering of 16,666,667 shares of its common stock. InnovAge also intends to grant the underwriters a 30-day option to purchase up to an additional 2,500,000 shares of InnovAge’s common stock. The initial public offering price is currently expected to be between $17.00 and $19.00 per share. InnovAge has applied to list its common stock on the Nasdaq Global Select Market (Nasdaq) under the ticker symbol “INNV.”
J.P. Morgan Securities LLC, Barclays Capital Inc., Goldman Sachs & Co. LLC and Citigroup are acting as joint lead book-running managers of the offering and as representatives of the underwriters. Robert W. Baird & Co. Incorporated, William Blair & Company, L.L.C., Piper Sandler & Co. and Capital One Securities, Inc. are acting as joint book-running managers of the offering. Loop Capital Markets LL
Gladstone Investment Corporation Prices Public Offering of 5 00% Notes due 2026
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.